EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity

Majid Eslami, Bahram Fadaee Dowlat, Shayan Yaghmayee iD, Anoosha Habibian iD, Saeedeh Keshavarzi, Valentyn Oksenych iD, Ramtin Naderian iD

Vaccines · 30.05.2025 · 13 (6) · 588

DOI: 10.3390/vaccines13060588 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 30.05.2025. Verfasst von Majid Eslami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center, Semnan University of Medical Sciences, Semnan 35147-99442, Iran. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of complex and rapidly evolving pathogens necessitates innovative vaccine platforms that move beyond traditional methods. This review explores the transformative potential of next-generation vaccine technologies, focusing on the combined use of synthetic biology, nanotechnology, and systems immunology. Synthetic biology provides modular tools for designing antigenic components with improved immunogenicity, as seen in mRNA, DNA, and peptide-based platforms featuring codon optimization and self-amplifying constructs. At the same time, nanotechnology enables precise antigen delivery and controlled immune activation through engineered nanoparticles such as lipid-based carriers, virus-like particles, and polymeric systems to improve stability, targeting, and dose efficiency. Systems immunology aids these advancements by analyzing immune responses through multi-omics data and computational modeling, which assists in antigen selection, immune profiling, and adjuvant optimization. This approach enhances both humoral and cellular immunity, solving challenges like antigen presentation, response durability, and vaccine personalization. Case studies on SARS-CoV-2, Epstein–Barr virus, and Mycobacterium tuberculosis highlight the practical application of these platforms. Despite promising progress, challenges include scalability, safety evaluation, and ethical concerns with data-driven vaccine designs. Ongoing interdisciplinary collaboration is crucial to fully develop these technologies for strong, adaptable, globally accessible vaccines. This review emphasizes next-generation vaccines as foundational for future immunoprophylaxis, especially against emerging infectious diseases and cancer immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

immunogenicityimmunoprophylaxisnext-generation platformsvaccinevirus-like particles

Autor:innen und Institutionen

  • Cancer Research Center, Semnan University of Medical Sciences, Semnan 35147-99442, Iran.
  • School of Medicine, Iran University of Medical Sciences, Tehran 14496-14535, Iran.
  • Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan 35147-99442, Iran.
  • Clinical Research Development Unit, Kowsar Educational, Research and Therapeutic Hospital, Semnan University of Medical Sciences, Semnan 35147-99442, Iran.
  • Faculty of Medicine, University of Bergen, 5020 Bergen, Norway.

ORCID-Profile: Shayan Yaghmayee, Anoosha Habibian, Valentyn Oksenych, Ramtin Naderian

Zitieren

APA

Eslami, M., Fadaee Dowlat, B., Yaghmayee, S., Habibian, A., Keshavarzi, S., Oksenych, V., & Naderian, R. (2025). Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity. Vaccines, 13(6), 588. https://doi.org/10.3390/vaccines13060588

Vancouver

Eslami M, Fadaee Dowlat B, Yaghmayee S, Habibian A, Keshavarzi S, Oksenych V, et al. Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity. Vaccines. 2025;13(6):588. doi:10.3390/vaccines13060588

BibTeX
@article{Eslami2025,
  author = {Eslami, Majid and Fadaee Dowlat, Bahram and Yaghmayee, Shayan and Habibian, Anoosha and Keshavarzi, Saeedeh and Oksenych, Valentyn and Naderian, Ramtin},
  title = {Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity},
  journal = {Vaccines},
  year = {2025},
  volume = {13},
  number = {6},
  pages = {588},
  doi = {10.3390/vaccines13060588}
}
Kostenlos starten →